Fidson Healthcare Plc has continued to raise its game with innovative products and services that redefine Nigeria’s pharmaceutical industry.
Among the drug maker’s innovative products is Astymin, which is gaining traction across the country. Fidson announced last year that it was pumping N7.5 b
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
ODINAKA ANUDU & ANGEL JAMES
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
